selected publications
- Two p53s in a Pod: Co-occurring plasma cell myeloma and therapy-related myeloid neoplasm following lenalidomide therapy. 2023 GET IT
- Myelodysplastic syndrome: Approach to diagnosis in the era of personalized medicine. Seminars in diagnostic pathology. 2023 Review GET IT
-
Myeloid sarcoma with NPM1 mutation may be clinically and genetically distinct from AML with NPM1 mutation: a study from the Bone Marrow Pathology Group.
Leukemia & lymphoma.
2023
Academic Article
GET IT
Times cited: 1 - NPM1-mutated acute myeloid leukemia: recent developments and open questions. Pathobiology : journal of immunopathology, molecular and cellular biology. 2023 Review GET IT
- Clinicopathologic and Molecular Analysis of Normal Karyotype Therapy-Related and De Novo Acute Myeloid Leukemia: A Multi-Institutional Study by the Bone Marrow Pathology Group. JCO precision oncology. 2023 Academic Article GET IT
- NPM1 mutations may be associated with adverse outcome in the setting of myeloid neoplasms with complex karyotype. Leukemia research. 2022 Letter GET IT
- Now you see me, now you don't: Isolated central nervous system recurrence of CD19-negative diffuse large B-cell lymphoma following CD19-directed CAR T-cell treatment. Cytopathology : official journal of the British Society for Clinical Cytology. 2022 Academic Article GET IT
-
Tyramide-conjugated DNA barcodes enable signal amplification for multiparametric CODEX imaging.
Communications biology.
2022
Academic Article
GET IT
Times cited: 4 -
Intestinal Abnormalities in Patients With SARS-CoV-2 Infection: Histopathologic Changes Reflect Mechanisms of Disease.
2022
GET IT
Times cited: 13 -
PKCλ/ι inhibition activates an ULK2-mediated interferon response to repress tumorigenesis.
Molecular cell.
2021
Academic Article
GET IT
Times cited: 7 -
Comparison of Multiple Clinical Testing Modalities for Assessment of NPM1-Mutant AML.
Frontiers in oncology.
2021
Academic Article
GET IT
Times cited: 103 -
Myelodysplastic syndromes with no somatic mutations detected by next-generation sequencing display similar features to myelodysplastic syndromes with detectable mutations.
American journal of hematology.
2021
Letter
GET IT
Times cited: 4 -
Pediatric Myelodysplastic Syndromes.
Clinics in laboratory medicine.
2021
Review
GET IT
Times cited: 2 -
Effect of DNMT3A variant allele frequency and double mutation on clinicopathologic features of patients with de novo AML.
Blood advances.
2021
Academic Article
GET IT
Times cited: 5 -
COVID-19 pulmonary pathology: a multi-institutional autopsy cohort from Italy and New York City.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
2020
Academic Article
GET IT
Times cited: 265 -
NPM1 Biology in Myeloid Neoplasia.
Current hematologic malignancy reports.
2020
Review
GET IT
Times cited: 6 -
Evidence for separate transformation to acute myeloid leukemia and blastic plasmacytoid dendritic cell neoplasm from a shared ancestral hematopoietic clone.
Leukemia & lymphoma.
2020
Letter
GET IT
Times cited: 5 -
Diagnostic workup of acute leukemias of ambiguous lineage.
American journal of hematology.
2020
Academic Article
GET IT
Times cited: 9 -
Multiparametric in situ imaging of NPM1-mutated acute myeloid leukemia reveals prognostically-relevant features of the marrow microenvironment.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
2020
Academic Article
GET IT
Times cited: 5 -
Clinicopathologic Characterization of Post-Renal Transplantation BK Polyomavirus-Associated Urothelial CarcinomaSingle Institutional Experience.
American journal of clinical pathology.
2020
Academic Article
GET IT
Times cited: 3 -
Overview of Tissue Imaging Methods.
Methods in molecular biology (Clifton, N.J.).
2020
Academic Article
GET IT
Times cited: 16 -
The microenvironmental niche in classic Hodgkin lymphoma is enriched for CTLA-4-positive T cells that are PD-1-negative.
Blood.
2019
Academic Article
GET IT
Times cited: 73 -
High NPM1 mutant allele burden at diagnosis correlates with minimal residual disease at first remission in de novo acute myeloid leukemia.
American journal of hematology.
2019
Academic Article
GET IT
Times cited: 21 -
Clinicopathologic and genetic characterization of nonacute NPM1-mutated myeloid neoplasms.
Blood advances.
2019
Academic Article
GET IT
Times cited: 32 -
Genomic and clinical characterization of B/T mixed phenotype acute leukemia reveals recurrent features and T-ALL like mutations.
American journal of hematology.
2018
Academic Article
GET IT
Times cited: 30 -
Leukemic-phase progression of aleukemic mast cell leukemia.
2018
GET IT
Times cited: 2 -
High NPM1-mutant allele burden at diagnosis predicts unfavorable outcomes in de novo AML.
Blood.
2018
Academic Article
GET IT
Times cited: 57 -
Improving bone marrow biopsy quality through peer discussion and data comparisons: A single institution experience.
International journal of laboratory hematology.
2018
Academic Article
GET IT
Times cited: 1 -
Implications of the tumor immune microenvironment for staging and therapeutics.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
2017
Review
GET IT
Times cited: 229 -
Phosphorylated Mechanistic Target of Rapamycin (p-mTOR) and Noncoding RNA Expression in Follicular and Hürthle Cell Thyroid Neoplasm.
Endocrine pathology.
2017
Academic Article
GET IT
Times cited: 7 -
Immunoregulatory roles of versican proteolysis in the myeloma microenvironment.
Blood.
2016
Academic Article
GET IT
Times cited: 98 -
Primary effusion lymphoma.
Archives of pathology & laboratory medicine.
2013
Review
GET IT
Times cited: 31